Clinical Trial Update: The Safety/Efficacy Of Daratumumab With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of combining daratumumab with belatacept in highly HLA-sensitized dialysis patients awaiting kidney transplanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• DARZALEX (daratumumab)
• Nulojix (belatacept)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Sensitisation, Highly Sensitised Dialysis Patients | Phase 2 | Status: TERMINATED